Bronchial aspirates glucose level as indicator for methicillin-resistant Staphylococcus aureus (MRSA) in intubated...

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Clinical Diagnostics

Background:

• Intubated, mechanically ventilated patients in the ICU are at high risk for hospital-acquired infections.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen in this patient population.
• Early identification of infection risk factors is crucial for timely intervention.

Purpose of the Study:

• To investigate whether glucose levels in bronchial aspirates can serve as an early indicator for MRSA infection risk.
• To assess the correlation between bronchial aspirate glucose and MRSA detection in critically ill patients.

Main Methods:

• A cohort of 50 critically ill patients requiring mechanical ventilation was studied.
• Bronchial aspirates were analyzed for glucose levels and microbiological analysis for MRSA.
• Patients were under tight glycemic control to minimize hyperglycemia effects.

Main Results:

• Glucose was detected in bronchial aspirates of 28 out of 50 patients (56%).
• MRSA was detected in 22 patients; 19 of these (86.4%) had positive glucose in their aspirates.
• A statistically significant increase in MRSA presence was observed in patients with glucose in bronchial aspirates (p=0.001).

Conclusions:

• Glucose in bronchial aspirates is a significant indicator of increased MRSA infection risk in intubated, mechanically ventilated ICU patients.
• This finding may facilitate earlier detection and targeted prevention strategies for MRSA.
• Bronchial glucose monitoring could be a valuable adjunctive diagnostic tool in critical care settings.